510(k) K042579
K042579 is an FDA 510(k) premarket notification submitted by The Binding Site for the device "BINDAZYME HUMAN ASCA IGG AND IGA EIA DIAGNOSTIC TEST KIT". The FDA issued a decision of Substantially Equivalent on July 28, 2005. The device falls under product code NBT (Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae)), a Class II device regulated under 21 CFR 866.5785. The Binding Site has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 28, 2005
- Date Received
- September 22, 2004
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae)
- Device Class
- Class II
- Regulation Number
- 866.5785
- Review Panel
- IM
- Submission Type